Opportunity Information: Apply for CDC RFA GH18 1806
This grant opportunity, titled "Strengthening Local Ownership for the Sustainable Provision of Comprehensive HIV/AIDS Services by Amhara Region Health Bureau of the Federal Democratic Republic of Ethiopia under PEPFAR," is a U.S. government-funded cooperative agreement meant to support and expand comprehensive HIV services across Ethiopia's Amhara Region. The central aim is to help drive progress toward the UNAIDS 90-90-90 goals for HIV epidemic control, meaning more people living with HIV know their status, more of those diagnosed are on sustained treatment, and more of those on treatment achieve viral suppression. A major theme running through the opportunity is transition and sustainability: the program is designed not only to deliver services, but to build the capacity of the Amhara Regional Health Bureau (RHB) to plan, manage, coordinate, and monitor HIV programming in a way that strengthens long-term local ownership.
The scope of work focuses on high-impact service delivery areas that directly affect HIV transmission, treatment outcomes, and overall health system performance. Activities include scaling and sustaining HIV Testing Services (HTS) so that more people are identified earlier and linked to care quickly. It also includes strengthening antiretroviral treatment (ART) programs, with emphasis on ongoing care and support so patients remain engaged in treatment and can reach and maintain viral suppression. Prevention of mother-to-child transmission (PMTCT) is another core component, reflecting the priority of preventing new pediatric HIV infections by ensuring pregnant and breastfeeding women have access to timely testing, treatment, and follow-up services. Integrated services for tuberculosis and HIV (TB/HIV) coinfection are included as well, recognizing TB as a leading cause of illness and death among people living with HIV and the need for coordinated screening, prevention, and treatment.
Beyond these primary service lines, the opportunity supports complementary interventions that strengthen comprehensive care. This includes prevention and treatment of sexually transmitted infections (STIs), which can increase HIV transmission risk and complicate clinical outcomes if left untreated. It also emphasizes laboratory services, which are critical for diagnosis and ongoing management, particularly for monitoring viral load and supporting quality clinical decision-making. Gender-based violence (GBV) care is explicitly included, signaling attention to the ways violence and coercion can increase HIV vulnerability and create barriers to accessing and staying in care. Quality improvement (QI) is another key element, intended to improve service performance and consistency as programs are scaled up and sustained across sub-national units (SNUs), which typically refers to administrative or geographic service delivery areas used for planning and reporting.
A defining feature of the opportunity is that it is structured as a cooperative agreement rather than a simple grant. In practical terms, that means the funder (the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Center for Global Health) anticipates substantial involvement in the project, such as ongoing technical collaboration, performance monitoring, and coordination to ensure activities align with PEPFAR strategies and reporting expectations. The program is expected to pursue maximum impact in line with PEPFAR goals: preventing new infections, finding people who are HIV-positive and linking them to services, keeping people living with HIV retained in care over time, and ensuring that patients on ART achieve optimal viral suppression.
From an administrative and funding standpoint, the opportunity is identified as CDC RFA GH18-1806 under CFDA 93.067, categorized as discretionary funding, with an anticipated single award. The award ceiling listed is $8.5 million, indicating the maximum expected funding level for the recipient under this notice of funding opportunity. The notice was created on September 29, 2017, with an original closing date of November 29, 2017, and it specifies that electronic applications were due by 11:59 p.m. Eastern Time on the deadline date. Eligibility is noted as "Others," with further clarification referenced in the original eligibility text, which typically means applicants must consult the full NOFO to confirm who can apply, though the description makes clear that the Amhara Regional Health Bureau is central to implementation and capacity-building for local ownership.
Overall, the grant opportunity is best understood as a targeted investment in both HIV service delivery and the regional systems needed to sustain those services over time. It combines direct program interventions (testing, treatment, PMTCT, TB/HIV, STI services, laboratory strengthening, GBV care) with broader health system and management supports (strategic planning, coordination, monitoring, and QI). The intended result is a stronger, locally led HIV response in the Amhara Region that can deliver measurable progress toward epidemic control by increasing diagnosis, improving linkage and retention, and boosting viral suppression among people receiving ART.Apply for CDC RFA GH18 1806
- The Department of Health and Human Services, Centers for Disease Control - CGH in the health sector is offering a public funding opportunity titled "Strengthening Local Ownership for the Sustainable Provision of Comprehensive HIV/AIDS Services by Amhara Region Health Bureau of the Federal Democratic Republic of Ethiopia under the President's Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
- This funding opportunity was created on Sep 29, 2017.
- Applicants must submit their applications by Nov 29, 2017 Electronically submitted applications must be submitted no later than 1159 p.m., ET, on the listed application due date.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $8,500,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
1) What is the title of this grant opportunity?
The opportunity is titled "Strengthening Local Ownership for the Sustainable Provision of Comprehensive HIV/AIDS Services by Amhara Region Health Bureau of the Federal Democratic Republic of Ethiopia under PEPFAR."
2) What type of funding mechanism is this?
This opportunity is a U.S. government-funded cooperative agreement, not a standard grant. A cooperative agreement typically involves substantial involvement by the funder during implementation (for example, technical collaboration and performance monitoring).
3) Which U.S. agency is funding and administering this opportunity?
The opportunity is administered by the U.S. Department of Health and Human Services (HHS), Centers for Disease Control and Prevention (CDC), Center for Global Health.
4) What is the main goal of the program?
The central goal is to support and expand comprehensive HIV services across Ethiopia's Amhara Region while strengthening long-term local ownership and sustainability through capacity-building of the Amhara Regional Health Bureau (RHB).
5) How does this opportunity relate to UNAIDS 90-90-90 targets?
The program is intended to drive progress toward the UNAIDS 90-90-90 goals for HIV epidemic control: increasing the number of people living with HIV who know their status, increasing sustained treatment among those diagnosed, and increasing viral suppression among those on treatment.
6) What does "local ownership" mean in the context of this award?
Local ownership refers to strengthening the ability of the Amhara Regional Health Bureau to plan, manage, coordinate, and monitor HIV programming so that services can be sustained over time under local leadership rather than relying primarily on external implementers.
7) What geographic area is the program focused on?
The focus is Ethiopia's Amhara Region.
8) Who is central to implementation and capacity-building under this program?
The Amhara Regional Health Bureau (RHB) is central to implementation and to the capacity-building emphasis described in the opportunity.
9) What are the primary HIV service delivery areas supported by this program?
The scope of work highlights high-impact service delivery areas, including HIV Testing Services (HTS), antiretroviral treatment (ART), prevention of mother-to-child transmission (PMTCT), and integrated TB/HIV services.
10) What is included under HIV Testing Services (HTS) in this opportunity?
The opportunity emphasizes scaling and sustaining HTS so more people can be identified earlier and linked to care quickly.
11) What is the focus for antiretroviral treatment (ART) activities?
ART programming is expected to be strengthened with emphasis on ongoing care and support so patients remain engaged in treatment and can reach and maintain viral suppression.
12) How is PMTCT addressed in this grant?
PMTCT is a core component, prioritizing prevention of new pediatric HIV infections by ensuring pregnant and breastfeeding women have timely access to testing, treatment, and follow-up services.
13) Why are TB/HIV integrated services included?
TB/HIV integration is included because tuberculosis is a leading cause of illness and death among people living with HIV, and coordinated screening, prevention, and treatment are needed.
14) Are sexually transmitted infection (STI) services part of the scope?
Yes. The opportunity supports prevention and treatment of STIs as complementary interventions, recognizing that untreated STIs can increase HIV transmission risk and complicate clinical outcomes.
15) What laboratory-related activities are emphasized?
Laboratory services are emphasized as critical for diagnosis and ongoing clinical management, including viral load monitoring and support for quality clinical decision-making.
16) Is gender-based violence (GBV) addressed in this program?
Yes. GBV care is explicitly included, reflecting attention to how violence and coercion can increase HIV vulnerability and create barriers to accessing and staying in care.
17) What does "quality improvement (QI)" mean within this opportunity?
QI is included as a key element intended to improve service performance and consistency as programs are scaled up and sustained across sub-national units (SNUs).
18) What are "sub-national units (SNUs)" in this context?
SNUs typically refer to administrative or geographic service delivery areas used for planning and reporting. The opportunity describes scaling and sustaining services across these units.
19) How does the cooperative agreement structure affect program implementation?
Because this is a cooperative agreement, CDC anticipates substantial involvement such as ongoing technical collaboration, performance monitoring, and coordination to keep activities aligned with PEPFAR strategies and reporting expectations.
20) What PEPFAR priorities are reflected in the program description?
The opportunity highlights maximum impact aligned with PEPFAR goals, including preventing new HIV infections, identifying people who are HIV-positive and linking them to services, retaining people living with HIV in care over time, and achieving optimal viral suppression among patients on ART.
21) What is the funding opportunity number and CFDA number?
The opportunity is identified as CDC RFA GH18-1806 under CFDA 93.067.
22) What is the funding category for this opportunity?
It is categorized as discretionary funding.
23) How many awards are anticipated?
The notice describes an anticipated single award.
24) What is the award ceiling?
The award ceiling is listed as $8.5 million, representing the maximum expected funding level for the recipient under this notice of funding opportunity.
25) When was the notice created and what was the original closing date?
The notice was created on September 29, 2017, with an original closing date of November 29, 2017.
26) How were applications submitted and what was the deadline time?
The notice specifies that electronic applications were due by 11:59 p.m. Eastern Time on the deadline date.
27) Who is eligible to apply based on the information provided?
Eligibility is noted as "Others," with further clarification referenced in the original eligibility text. Based on the description provided here, applicants would need to consult the full notice of funding opportunity (NOFO) to confirm eligibility details.
28) What is the overall approach of the opportunity: service delivery, systems strengthening, or both?
Both. The opportunity combines direct HIV service delivery interventions (HTS, ART, PMTCT, TB/HIV, STI services, laboratory strengthening, and GBV care) with broader management and health system supports (strategic planning, coordination, monitoring, and quality improvement) to strengthen sustainability and local leadership.
29) What kinds of measurable results does the opportunity aim to support?
The intended results described include increased HIV diagnosis, improved linkage to services, improved retention in care, and increased viral suppression among people receiving ART, contributing to epidemic control in the Amhara Region.
30) What is the core sustainability and transition theme in this program?
A central theme is transition and sustainability: the program is designed not only to deliver HIV services, but also to build the Amhara RHB's capacity to lead and sustain HIV programming over the long term through stronger planning, management, coordination, monitoring, and quality improvement.
Browse more opportunities from the same category: Health
Next opportunity: NAGPRA Consultation/Documentation Grants FY2018
Previous opportunity: CESU GRPL – Leadership, Coordination, and Administrative Oversight for the Great Plains Cooperative Ecosystem Studies Unit
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH18 1806
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH18 1806) also looked into and applied for these:
| Funding Opportunity |
|---|
| Strengthening Local Ownership for the Sustainable Provision of Comprehensive HIV/AIDS Services by Tigray Regional Health Bureau of the Federal Democratic Republic of Ethiopia under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH18 1810 Funding Number: CDC RFA GH18 1810 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $4,700,000 |
| Center of Excellence for Comprehensive Integrated HIV Care and Treatment Services in Lilongwe, Malawi under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH18 1816 Funding Number: CDC RFA GH18 1816 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $7,000,000 |
| Limited Competition: Brain Tissue Resource Center for Alcohol Research (R28) Apply for PAR 17 305 Funding Number: PAR 17 305 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Strengthen Brazil's Response to HIV and Other Infectious Diseases through Prevention, Treatment, Care, Laboratory, Strategic Information, and Epidemiology and Surveillance Activities under the President's Emergency Plan for AIDS Relief (PEP Apply for CDC RFA GH18 1847 Funding Number: CDC RFA GH18 1847 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $6,000,000 |
| Secure Data Sharing Tool to Support De-duplication of Cases in the National HIV Surveillance System (NHSS) Apply for CDC RFA PS18 1805 Funding Number: CDC RFA PS18 1805 Agency: Department of Health and Human Services, Centers for Disease Control - NCHHSTP Category: Health Funding Amount: $400,000 |
| Tobacco Regulatory Science (R01 Clinical Trial Optional) Apply for RFA OD 18 002 Funding Number: RFA OD 18 002 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: $300,000 |
| Tobacco Regulatory Science Small Grant Program for New Investigators (R03 Clinical Trial Optional) Apply for RFA OD 18 001 Funding Number: RFA OD 18 001 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: $50,000 |
| Tobacco Regulatory Science (R21 Clinical Trial Optional) Apply for RFA OD 18 003 Funding Number: RFA OD 18 003 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: $200,000 |
| CDC's Collaboration with Academia to Strengthen Public Health Workforce Capacity Apply for CDC RFA OE17 17010201SUPP18 Funding Number: CDC RFA OE17 17010201SUPP18 Agency: Department of Health and Human Services, Centers for Disease Control - CSELS Category: Health Funding Amount: $241,000 |
| Epidemiology and Risk of Novel and Seasonal Influenza Viruses and the Value of Prevention, Treatment, and Mitigation Strategies for Annual Epidemic and Pandemic Preparedness and Response in Thailand Apply for RFA IP 18 005 Funding Number: RFA IP 18 005 Agency: Department of Health and Human Services, Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: $2,000,000 |
| Public Health Epidemiology of Influenza Virus Infection and Control in China Apply for RFA IP 18 004 Funding Number: RFA IP 18 004 Agency: Department of Health and Human Services, Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: $2,000,000 |
| Offender Reentry Program Apply for TI 18 003 Funding Number: TI 18 003 Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Adminis Category: Health Funding Amount: $425,000 |
| Preventing HIV/AIDS in Vulnerable Populations in South Africa Apply for 72067418RFA00002 Funding Number: 72067418RFA00002 Agency: Agency for International Development, South Africa USAID-Pretoria Category: Health Funding Amount: $150,000,000 |
| Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional) Apply for PAS 18 188 Funding Number: PAS 18 188 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional) Apply for PAS 18 187 Funding Number: PAS 18 187 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Epicenters for the Prevention of Healthcare-Associated Infections (HAIs); Cycle II Multicenter Program Studies Apply for RFA CK 18 001 Funding Number: RFA CK 18 001 Agency: Department of Health and Human Services, Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: $3,000,000 |
| Community-Based Coalition Enhancement Grants To Address Local Drug Crises Apply for SP 18 001 Funding Number: SP 18 001 Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Adminis Category: Health Funding Amount: $50,000 |
| Determining and Monitoring Health Conditions Among US-Bound Refugees and Other Globally Mobile Populations Apply for RFA CK 18 003 Funding Number: RFA CK 18 003 Agency: Department of Health and Human Services, Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: $700,000 |
| Clinical Trial Planning: Therapeutic/Indication Pairing Strategies (U34) (Clinical Trials Not Allowed) Apply for PAR 18 462 Funding Number: PAR 18 462 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: $225,000 |
| Etiology and Outcome of Inflammatory Bowel Disease Apply for RFA DP 18 001 Funding Number: RFA DP 18 001 Agency: Department of Health and Human Services, Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: $800,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH18 1806", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.